"Controlling the Use of Performance Enhancing Drugs in Sports: How to Maintain Competitive Balance without Destroying Due Process"

04/22/2010 12:00 pm
04/22/2010 1:30 pm

 

The panel will address the contemporary issues and challenges facing sport leagues and governing bodies in testing athletes for the use of performance enhancing drugs.  Topics for discussion include testing for human growth hormone, what qualifies as a PED, proper sanctions imposed on athletes who test positive, the impact of PEDs on a level playing field, protecting the athlete's interest as well as the amorphous topic of due process, and where the future is headed.

 
Date:  April 22, 2010
Time:  12:00 – 1:30
Room: 585
 
Moderator
Gina Donahoo, Assist. Prof. of Lawyering Process
 
Panelists:
Josh Kane, Associate Counsel & Drug Testing Program Administrator, LPGA
Andy Levinson, Executive Director, Anti-Doping Program, PGA TOUR
Travis Tygart, Chief Executive Officer, United States Anti-Doping Agency